Skip to search formSkip to main contentSkip to account menu

S-18886

Known as: S18886 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

terutroban

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A thromboxane A 2 / prostaglandin H 2
Acute thrombosis is a threat in patients undergoing percutaneous coronary intervention with stent implantation. Our objective was… 
2013
2013
Acidosis prevents and alkalosis augments endothelium-dependent contractions in mouse arteries
Changes in pH modulate the responsiveness of vascular smooth muscle cells to vasoconstrictor stimuli, but their effect on… 
2007
2007
THROMBOXANE A2/PROSTAGLANDIN H2 RECEPTOR BLOCKER (S18886) SHOWS ANTITHROMBOTIC EFFICACY SIMILAR TO ASPIRIN PLUS CLOPIDOGREL IN STENT-INDUCED THROMBOSIS
2006
2006
Potential effects of S18886 on atherosclerotic plaque stability
Cardiovascular diseases are responsible for over 50% of all deaths in Western society, with the underlying cause of most a single… 
2005
2005
The Thromboxane Receptor Antagonist S18886 influence the stability of atherosclerosis in ApoE Null Mice
Objectives To investigate whether thromboxane receptor antagonist S18886 inhibits infiltrating macrophages to vessel wall and… 
2005
2005
Results TP Antagonism , but Not Combined Inhibition of COX-1 and COX-2 , Retards Atherogenesis in DKOs Fed a High-Fat Diet
Background—Antagonism or deletion of the receptor (the TP) for the cyclooxygenase (COX) product thromboxane (Tx)A2, retards… 
2005
2005
The thromboxane receptor antagonist S18886 influences the atherosclerosis in ApoE Null Mice
Objectives To investigate whether thromboxane receptor antagonist S18886 inhibits infiltrating macrophages to vessel wall and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)